Hyperion Therapeutics | search
Click here to view Hyperion Therapeutics news from 60+ newspapers.
Bookmark or Share- Horizon Pharma to Acquire Hyperion Therapeutics for $1.1BHorizon Pharma will acquire Hyperion Therapeutics for about $1.1 billion, the companies said today, in a deal that adds two complementary products to the buyer’s orphan disease drug portfolio.
- AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLCTHOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.
- Hyperion Therapeutics Completes Initial Public Offering and Announces ...Hyperion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.
- Horizon scoops up Hyperion and its rare disease portfolio for $1.1BIreland-based Horizon Pharma ($HZNP) snatched up Hyperion Therapeutics ($HPTX) for $1.1 billion to get its hands on the company's rare disease meds, diversifying its portfolio and expanding its ...
- Horizon Pharma acquires Hyperion Therapeutics for $1.1bnShare this article. Irish biopharmaceutical firm Horizon Pharma has completed the acquisition of US-based Hyperion Therapeutics for around $1.1bn. The deal was first announced at the end of March. Horizon noted that acquisition of Hyperion has been completed following successful tender for 86% of its outstanding shares.
More
